Recent News

• 10.28.2026 - Balchem Corporation to Participate in Baird’s Global Industrial Conference on November 11, 2026
• 10.26.2026 - Stronger Bones with Vitamin K2: How Calcium, Vitamin D3, and MK-7 Work Together for Bone Health
• 10.23.2026 - Balchem Reports Third Quarter 2026 Financial Results
• 10.09.2026 - Balchem Announces Conference Call for Third Quarter 2026 Financial Results
• 09.29.2026 - K2VITAL™ – Science Done Right.
• 09.23.2026 - Landmark Circulation Publication Validates K2VITAL™ DELTA in the Largest Clinical Trial of Vitamin K2 (MK-7) and D3 for Coronary Calcification
• 09.10.2026 - New Study Shows Optifolin+® Demonstrates Superior Methylation Capacity
• 09.09.2026 - Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
• 08.27.2026 - Vitamin K2 and Vascular Health: A New Look at How Arteries Function
• 08.19.2026 - New Research Shows Only 30% of Calcium in Global Food Supply Is Bioavailable

Recent Filings

• 10.23.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.23.2026 - EX-99.1 EX-99.1
• 10.23.2026 - 8-K Current report
• 09.24.2026 - 3 Initial statement of beneficial ownership of securities
• 07.31.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.31.2026 - 8-K Current report
• 07.31.2026 - EX-99.1 EX-99.1
• 07.27.2026 - 8-K Current report
• 06.22.2026 - 8-K Current report
• 06.18.2026 - 11-K Annual report of employee stock purchase, savings and similar plans